سعر جويبوكس 30مجم 3 قرص 2022

Joypox 30 mg (Sedico / Rameda): dapoxetine 30 mg film-coated tablets, a short-acting SSRI taken on demand for premature ejaculation; pack of 3 tablets.

• Premature ejaculation in adult men aged 18 to 64 years who meet the diagnostic criteria; on-demand use only.Population: Men 18-64 yearsLäkemedelsverket (Swedish Medical Products Agency)

• Most common and dose-related: nausea (11.0% at 30 mg, 22.2% at 60 mg), dizziness, headache, diarrhoea, insomnia and fatigue; syncope and orthostatic hypotension have been reported.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)

• Significant cardiac conditions: heart failure (NYHA II-IV), conduction abnormalities (e.g. AV block, sick sinus syndrome), significant ischaemic or valvular heart disease, or a history of syncope.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• History of mania or severe depression.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• Concomitant MAOIs, thioridazine, SSRIs/SNRIs/tricyclic antidepressants or other serotonergic medicines/herbal products, or within 14 days of stopping them.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)

• Only for men with diagnosed premature ejaculation; not for men with erectile dysfunction using PDE5 inhibitors.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• Orthostatic hypotension and syncope (with or without prodromal symptoms) have occurred; take a careful medical history and perform an orthostatic test before starting; patients should avoid situations where injury could result (e.g. driving) if prodromal symptoms occur.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• Avoid alcohol, which may increase neurocognitive adverse effects and the risk of syncope.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)

• Monoamine oxidase inhibitorsRisk of serious, sometimes fatal serotonergic reactions; contraindicated with or within 14 days of MAOIs, and MAOIs should not be started within 7 days after stopping dapoxetine.Läkemedelsverket (Swedish Medical Products Agency)
• ThioridazineDapoxetine may raise thioridazine levels (CYP2D6 inhibition), increasing QTc prolongation; contraindicated.Läkemedelsverket (Swedish Medical Products Agency)
• PDE5 inhibitorsPossible reduced orthostatic tolerance; should not be used together.Läkemedelsverket (Swedish Medical Products Agency)

• Not indicated for use by women; animal studies do not indicate harmful effects on fertility, pregnancy or embryo-fetal development.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• It is not known whether dapoxetine or its metabolites are excreted in human milk.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)

English text not available for this section.